Abstract
The transdermal drug delivery systems, also known as TDDS, are the most effective alternative to the oral and parenteral routes to deliver therapeutic molecules across the skin in order to produce systemic effects. TDDS possess several benefits such as self-administrable nature, escape of first-pass metabolism, minimize dose, less side effects, better dosage regimen, termination of dosing at any time, absence of gastric irritation, and improved patient compliance. In the earlier scenario, TDDS was indicated only for the transdermal patches. These patches include matrix devices, reservoir type, micro-reservoir forms, and adhesive controlled systems. In the present situation, various state of the art technologies were introduced in advancing TDDS utilization. For passive drug delivery, nanovesicles, polymeric nanocarriers adhesive-controlled and nanoemulsions were implemented. Active delivery strategies include iontophoresis, sonophoresis, electroporation, photomechanical waves, thermal ablation, and microneedle technology. The earlier transdermal patches are utilized only to deliver the small molecule drugs whereas the latest versions of TDDS provide a comprehensive selection of molecules from low molecular weight drugs to macromolecule proteins. Among them, microneedles are proven to deliver several macromolecular biomolecules such as vaccines, extracted proteins, and whole viral particles. In this chapter, we are going to know about the basics of TDDS such as mechanisms of skin permeation, factors influencing transdermal permeation, basic ingredients for transdermal patches, categories of formulations, and permeation promoters. In addition to the basic knowledge, we are also about to explore the transdermal patches available in the market and the latest technologies introduced in TDDS. In near future, we can expect several new innovative tools to be marked within the context of the transdermal delivery of drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akhtar N et al (2020) Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed Tech (Berl) 65(3):243–272
Al Hanbali OA et al (2019) Transdermal patches: design and current approaches to painless drug delivery. Acta Pharm 69(2):197–215
Ali S, Shabbir M, Nabeel Shahid M (2015) The structure of skin and transdermal drug delivery system—a review. Res J Pharm Technol 8:103
Al-Khamis KI, Davis SS, Hadgraft J (1986) Microviscosity and drug release from topical gel formulations. Pharm Res 3(4):214–217. https://doi.org/10.1023/A:1016386613239
Alkilani AZ, Nasereddin J (2022) Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. 14(6)
Allen LV, Popovich NG, Ansel HC (2012) Ansel's pharmaceutical dosage forms and drug delivery systems
Andrews SN, Jeong E, Prausnitz MR (2013) Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 30(4):1099–1109. https://doi.org/10.1007/s11095-012-0946-7
Arijit D, Sibaji G, Biplab KD, Sudip D (2010) A novel technique for treating the type ll diabetes by transdermal patches prepared by using multiple polymer complexes. Int J Pharma Res Dev 9:195–204
Barry BW (1988) Action of skin penetration enhancers? The lipid protein partitioning theory. Int J Cosmet Sci 10(6):281–293. https://doi.org/10.1111/j.1467-2494.1988.tb00028.x
Benson HAE et al (2019) Topical and transdermal drug delivery: from simple potions to smart technologies. Curr Drug Deliv 16(5):444–460
Berlin CM (1997) Clinical report—alternative routes of drug administration—advantages & disadvantages (subject review). Pediatrics
Bouwstra JA, Gooris GS (2010) The lipid organisation in human stratum corneum and model systems. Open Dermatol J 4(1):10–13. https://doi.org/10.2174/1874372201004010010
Chantasart D, Li SK (2012) Structure enhancement relationship of chemical penetration enhancers in drug transport across the stratum corneum. Pharmaceutics 4(1):71–92. https://doi.org/10.3390/pharmaceutics4010071
Chen X et al (2020) Electroporation-enhanced transdermal drug delivery: effects of logP, pK(a), solubility and penetration time. Eur J Pharm Sci 151:105410
Chien YW, Banga AK (1989) Iontophoretic (transdermal) delivery of drugs: overview of historical development. J Pharm Sci 78(5):353–354
Choudhary N, Singh AP (2021) Transdermal drug delivery system: a review. Indian J Pharm Pharmacol 8(1):5–9
Dardano P et al (2015) A photolithographic approach to polymeric microneedles array fabrication. Materials (Basel) 8(12):8661–8673
Das A, Ahmed A (2017) Natural permeation enhancer for transdermal drug delivery system and permeation evaluation: a review. Asian J Pharm Clin Res 10:5
Dermol-Černe J, Pirc E, Miklavčič D (2020) Mechanistic view of skin electroporation—models and dosimetry for successful applications: an expert review. Expert Opin Drug Deliv 17(5):689–704
Dhal S, Pal K, Giri S (2020) Transdermal delivery of gold nanoparticles by a soybean oil-based oleogel under iontophoresis. ACS Appl Bio Mater 3(10):7029–7039
Du H et al (2019) Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces 11(46):43588–43598
Frei A et al (2003) A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain. J Pain Palliat Care Pharmacother 17(2):5–26
Gandhi K et al (2012) Transdermal drug delivery: a review
Giacomoni PU, Dong K, Collins D, Pernodet N, Yarosh D (2011) Use of reconstructed skin specimens to analyze stratum corneum remodeling and epidermal modifications. In: Skin biopsy—perspectives. InTech https://doi.org/10.5772/23023
Govil SK (1988) Drug delivery devices. In: Tyle P (ed). Marcel Dekker, New York
Green PG (1996) Iontophoretic delivery of peptide drugs. J Control Release 41(1–2):33–48. https://doi.org/10.1016/0168-3659(96)01354-5
Hadgraft J, Lane ME (2009) Transepidermal water loss and skin site: a hypothesis. Int J Pharm 373(1–2):1–3. https://doi.org/10.1016/j.ijpharm.2009.02.007
Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74
Igarashi T, Nishino K, Nayar SK (2007) The appearance of human skin: a survey. Found Trends® Comput Graph Vis 3(1):1–95. https://doi.org/10.1561/0600000013
Ita K (2015a) Transdermal delivery of drugs with microneedles-potential and challenges. Pharmaceutics 7(3):90–105
Ita KB (2015b) Chemical penetration enhancers for transdermal drug delivery—success and challenges. Curr Drug Deliv 12(6):645–651
Jayaprakash R, Hameed J, Anupriya A (2017) An overview of transdermal delivery system. Asian J Pharm Clin Res 10(10):36. https://doi.org/10.22159/ajpcr.2017.v10i10.19909
Jayaswal SB, Sood R (1987) Transdermal drug delivery system—a review. Eastern Pharm 30(357):47–50
Jeong WY et al (2019) Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia. Biomater Res 23:16
Jeong WY et al (2021) Recent advances in transdermal drug delivery systems: a review. Biomater Res 25(1):24
Karande P, Mitragotri S (2009) Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochimica et Biophysica Acta (BBA) Biomembranes 1788(11):2362–2373. https://doi.org/10.1016/j.bbamem.2009.08.015
Kavadya Y, Behera B, Mohanty P, Routray D, Ghosh S, Das L (2018) Study of physiological and pathological skin changes in neonates: an east Indian perspective. Indian J Paediatr Dermatol 19(1):40. https://doi.org/10.4103/ijpd.ijpd_21_17
Keleb E, Sharma RK, Mosa EB, Aljahvi AZ (2010) Transdermal drug delivery system-design and evaluation. Int J Adv Pharm Sci 1:201–211
Kim HM et al (2012) Transdermal drug delivery using disk microneedle rollers in a hairless rat model. Int J Dermatol 51(7):859–863
Kornick CA et al (2003) Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 26(13):951–973
Kumar R, Philip A (2007) Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res 6(1):633–644. https://doi.org/10.4314/tjpr.v6i1.14641. ISSN: 1596-5996
Kumar SR, Jain A, Nayak S (2012) Development and evaluation of transdermal patches of colchicine. Pharm Lett 4(1):330–343
Kusum Devi V, Saisivam S, Maria GR, Deepti PU (2003) Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 29(5):495–503. https://doi.org/10.1081/DDC-120018638
Lee H et al (2018) Device-assisted transdermal drug delivery. Adv Drug Deliv Rev 127:35–45
Leppert W et al (2018) Transdermal and topical drug administration in the treatment of pain. Molecules 23(3)
Lin CH, Aljuffali IA, Fang JY (2014) Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv 11(4):599–614
Mitragotri S, Edwards DA, Blankschtein D, Langer R (1995) A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci 84(6):697–706. https://doi.org/10.1002/jps.2600840607
Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF (2007) Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J 1(1):36–59. https://doi.org/10.2174/1874126600701010036
Neupane R et al (2021) Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities. Pharmaceutics 13(7):960. https://doi.org/10.3390/pharmaceutics13070960
Panchaguinla R (1997) Transdermal delivery of drug. Indian J Pharmacol 29:140
Pandey D, Akhilesh D, Prabhakara P, Kamath J (2012) Transdermal drug delivery system: a novel drug delivery system. Int Res J Pharm 3(5):89–94
Parivesh S, Sumeet D, Abhishek D (2010) Design, evaluation, parameters and marketed products of transdermal patches: a review. J Pharm Res 3(2):235–240
Park J et al (2019) Enhanced transdermal drug delivery by sonophoresis and simultaneous application of sonophoresis and iontophoresis. AAPS PharmSciTech 20(3):96
Pastore MN et al (2015) Transdermal patches: history, development and pharmacology. Br J Pharmacol 172(9):2179–2209
Pathan I, Setty C (2009) Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8(2). https://doi.org/10.4314/tjpr.v8i2.44527
Peña-Juárez MC, Guadarrama-Escobar OR, Escobar-Chávez JJ (2022) Transdermal delivery systems for biomolecules. J Pharm Innov 17(2):319–332
Pires LR et al (2019) A perspective on microneedle-based drug delivery and diagnostics in paediatrics. J Pers Med 9(4)
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268
Rastogi V, Yadav P (2012) Transdermal drug delivery system: an overview. Asian J Pharm 6(3)
Rizwan M, Aqil M, Talegoankar S, Azeem A, Sultana Y, Ali A (2009) Enhanced transdermal drug delivery techniques: an extensive review on patents. Recent Pat Drug Deliv Formul 3(2):105–124
Roohnikan M et al (2019) A snapshot of transdermal and topical drug delivery research in Canada. Pharmaceutics 11(6)
Roy N et al (2017) On permeation enhancers: a major breakthrough in drug delivery technology
Ruby PK, Pathak SM, Aggarwal D (2014) Critical attributes of transdermal drug delivery system (TDDS)—a generic product development review. Drug Dev Ind Pharm 40(11):1421–1428
Sandhyarani G, Madhuri M (2018) Development and evaluation of fast disintegrating films and tablets of Valsartan. Int J Med Sci Pharma Res 4(1):17. https://doi.org/10.22270/ijmspr.v4i1.23
Sankar V, Johnson DB, Sivan V, Ravich V, Raghuraman S, Velrajan G, Palaniappan R, Rajasekar S (2003) Design and evaluation of nifedipine transdermal patches. Indian J Pharm Sci 65(5):510
Shaila L, Pandey S, Udupa N (2006) Design and evaluation of matrix type membrane controlled transdermal drug delivery system of nicotine suitable for use in smoking cessation. Indian J Pharm Sci 68(2):829–831. https://doi.org/10.4103/0250-474X.25711
Shakya AK et al (2019) Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice. J Control Release 314:38–47
Shinde AJ, Garala KC, More HN (2008) Development and characterization transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm (AJP) 2(4):265–269. https://doi.org/10.4103/0973-8398.45044
Singh S, Singh J (1993) Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev 13
Singh MC, Naik AS, Sawant SD (2010) Transdermal drug delivery systems with major emphasis on transdermal patches: a review. J Pharm Res 3(10):2537–2543
Sinha VR, Kaur MP (2000) Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26(11):1131–1140. https://doi.org/10.1081/DDC-100100984
Sonjoy M, Thimmasetty J, Ratan GN, Kilarimath BH (2011) Formulation and evaluation of carvedilol transdermal patches. Int Res J Pharm 2(1):237–248
Sood A, Panchagnula R (1999) Role of dissolution studies in controlled release drug delivery systems. STP Pharma Sci 9(2):157–168
Szunerits S, Boukherroub R (2018) Heat: a highly efficient skin enhancer for transdermal drug delivery. Front Bioeng Biotechnol 6:15
Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK (2007) The transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 8(1):13–20. https://doi.org/10.1208/pt0801002
Varvel JR et al (1989) Absorption characteristics of transdermally administered fentanyl. 70(6):928–934
Verma PR, Iyer SS (2000) Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation. Drug Dev Ind Pharm 26(4):471–476. https://doi.org/10.1081/DDC-100101257
Verma S, Ojha A (2018) Transdermal drug delivery system: a review. Int J Med Sci Pharma Res 4(1):1–9. https://doi.org/10.22270/ijmspr.v4i1.21
Vishvakarma P, Aggrawal S, Sharma R, Sharma S (2012) Transdermal drug delivery system: review. Int Res J Pharm 23(5):50–53
Wade A, Weller PJ (1994) Handbook of pharmaceutical excipients. American Pharmaceutical Publishing Association, Washington DC, pp 362–366
Wang Y et al (2022) Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Drug Deliv Transl Res 12(1):15–26
Weiner E, Victor A, Johansson ED (1976) Plasma levels of d-Norgestel after oral administration. Contraception 14:563–570. Keith AD (1983) Polymer matrix consideration for transdermal devices. Drug Dev Ind Pharm 9:605–625
Wiechers J (1992) Use of chemical penetration enhancers in transdermal drug delivery–possibilities and difficulties. Acta Pharm Nord 4(2):123
Wokovich A et al (2006) Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 64:1–8
Yamamoto T, Katakabe K, Akiyoshi K, Kan K, Asano T (1990) Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes Res Clin Pract 8:19–22. https://doi.org/10.1016/0168-8227(90)90091-7
Zhang Y et al (2019) Advances in transdermal insulin delivery. Adv Drug Deliv Rev 139:51–70
Zhao Z, Chen Y, Shi Y (2020) Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis. RSC Adv 10(24):14040–14049
Acknowledgements
The principal investigator laboratory is supported by Science and Engineering Research Board (SERB) via Start-up Research Grant (SRG) [grant no. SRG/2021/002312] and the Empowerment and Equity Opportunities for Excellence in Science (EMEQ) grant [grant no. EEQ/2022/000218] during the scripting of the book chapter. The book chapter is related to the above research grants. The authors would like to acknowledge biorender (online imaging) service providers for the assistance in drawing images.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Conflict of Interest
The authors declare that there is no conflict of interest in publishing the book chapters.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, V. et al. (2023). Transdermal Drug Delivery Systems. In: Santra, T.S., Shinde, A.U.S. (eds) Advanced Drug Delivery. Studies in Mechanobiology, Tissue Engineering and Biomaterials, vol 26. Springer, Singapore. https://doi.org/10.1007/978-981-99-6564-9_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-6564-9_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-6563-2
Online ISBN: 978-981-99-6564-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)